News

   

Zephyrus Innovations announces US FDA approval for its Aeroject™ 3ml safety syringe

Aeroject™ 3ml safety syringe is a single-use, affordable,…

Leucid Bio provides business update and outlook for 2023

Proprietary Lateral CAR Platform achieved pre-clinical…

Futura Medical to present MED3000 FM71 data at the European Society for Sexual Medicine Congress 2023

Futura Medical plc (AIM: FUM), a pharmaceutical company developing…

Optimum Expands its Team with Senior Investor Relations and Communications Hires Jonathan Edwards and Hana Malik

14 February 2023 – Optimum Strategic Communications (“Optimum”),…

Novo Holdings Venture Investments team Newsletter

The Novo Holdings Venture Investments team has published its…

Sequana Medical announces 2022 Full Year Results and 2023 Outlook

alfapump® – successful primary endpoint read-out of North…

Sequana Medical announces grant of additional DSR® patent in United States

Ghent, Belgium – 1 February 2023 – Sequana Medical NV (Euronext…

Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, M.D., as Chief Medical Officer

Dr. Gericke brings extensive experience in the research and…

Neuraxpharm announces closing of acquisition of established products from Sanofi

Düsseldorf and Barcelona – February 1, 2023 – Neuraxpharm…

Pre-launch of MED3000 Eroxon™ ahead of H1 2023 launch

Futura Medical plc (AIM: FUM), a pharmaceutical company developing…

2022 Novo Holdings Seed Investments team Re-view/Business Update

Two successful exits – Syndesi and BioPhero Four portfolio…

Neuraxpharm completes its presence in the Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg

Belgium team to expand under Country Manager, Dr Pierre-Hervé…

NeoPhore completes extension to Series B financing to further advance discovery pipeline

Scientific milestones achieved significantly ahead of schedule Cambridge,…

We’d love to hear from you.

For more information about Optimum Strategic Communications, please get in touch.

© Optimum Strategic Communications.